Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ingelsson

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2014
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseHlin Kvartsberg, Flora H Duits, Martin Ingelsson, et al.
Acta Neuropathologica Communications|February 5, 2024
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletionMaría Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2023
Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 statusJulie Le Borgne, , Philippe Amouyel, et al.
The New England Journal of Medicine|March 5, 2005
Family-based association between Alzheimer's disease and variants in UBQLN1Lars Bertram, Mikko Hiltunen, Michele Parkinson, et al.
Science Translational Medicine|May 3, 2019
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brainAtsushi Aoyagi, Carlo Condello, Jan Stöhr, et al.
Journal of Neurochemistry|February 1, 2013
Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutationTherese Fagerqvist, Veronica Lindström, Eva Nordström, et al.
Science (New York, N.Y.)|December 6, 2014
Mutagenesis. Smoking is associated with mosaic loss of chromosome YJan P Dumanski, Chiara Rasi, Mikael Lönn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's diseaseCarlo Condello, Thomas Lemmin, Jan Stöhr, et al.
Annals of Clinical and Translational Neurology|June 15, 2021
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's diseaseSofia Bergström, Julia Remnestål, Jamil Yousef, et al.
Neurobiology of Disease|November 5, 2021
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's diseaseEva Nordström, Fredrik Eriksson, Jessica Sigvardson, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2014
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseHlin Kvartsberg, Flora H Duits, Martin Ingelsson, et al.
Acta Neuropathologica Communications|February 5, 2024
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletionMaría Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2023
Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 statusJulie Le Borgne, , Philippe Amouyel, et al.
The New England Journal of Medicine|March 5, 2005
Family-based association between Alzheimer's disease and variants in UBQLN1Lars Bertram, Mikko Hiltunen, Michele Parkinson, et al.
Science Translational Medicine|May 3, 2019
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brainAtsushi Aoyagi, Carlo Condello, Jan Stöhr, et al.
Journal of Neurochemistry|February 1, 2013
Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutationTherese Fagerqvist, Veronica Lindström, Eva Nordström, et al.
Science (New York, N.Y.)|December 6, 2014
Mutagenesis. Smoking is associated with mosaic loss of chromosome YJan P Dumanski, Chiara Rasi, Mikael Lönn, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's diseaseCarlo Condello, Thomas Lemmin, Jan Stöhr, et al.
Annals of Clinical and Translational Neurology|June 15, 2021
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's diseaseSofia Bergström, Julia Remnestål, Jamil Yousef, et al.
Neurobiology of Disease|November 5, 2021
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's diseaseEva Nordström, Fredrik Eriksson, Jessica Sigvardson, et al.
Pageof 22